Frederick Larcombe

Mr. Fred Larcombe, CPA, is a Principal at Crimson Partners, Chief Financial Officer at iBIO, Chief Financial Officer, Secretary & Director at Heartland Bridge Capital, Inc., Chief Financial Officer at The Riderwood Group, Inc., and Chief Financial Officer at Heartland Bridge Capital, Inc. (Private Equity).
Mr. Larcombe has served as Chief Financial Officer for: Xenomics, a developer of DNA diagnostic tests; FermaVir Pharmaceuticals, a pharmaceutical development company; MicroDose Technologies, a drug delivery device company; and Genesis Direct, an internet retailer.
He started his professional career with PriceWaterhouseCoopers (PwC).
Mr. Larcombe received his BS in Accounting from Seton Hall University, and is a graduate of the Management Development Program at Harvard Business School.